Laurin Angermeier, MSc in Applied Neuroscience

Laurin Angermeier is a neuroscientist and psychedelic integration practitioner based in Berlin, working at the intersection of research, applied psychedelic work, and mental health innovation. He holds a Master’s degree in Applied Neuroscience from King’s College London, where his academic work focused on psychedelic-assisted approaches to depression, emotional regulation, and the neurobiology of mental health.

He is trained in psychedelic facilitation and integration through the Center for Medicinal Mindfulness and Synthesis Institute, with a strong emphasis on preparation, mindfulness-based guidance, nervous-system regulation, and post-experience integration. Laurin has also supported individuals through challenging and high-intensity psychedelic experiences via MAPS-affiliated harm reduction initiatives.

A central focus of his work is the therapeutic use of cannabis as a psychedelic medicine within structured, neuroscience-informed contexts. He works with individuals, couples and groups, with particular attention to emotional regulation, attachment dynamics, neurodivergence, and embodied nervous-system awareness.

Alongside his facilitation and integration work, Laurin brings experience from the digital health and psychedelic startup ecosystem. He contributes to the development of evidence-informed therapeutic frameworks, practitioner education, and the translation of neuroscience research into scalable, ethically grounded mental health products and services.